2026. BIOACTIVE CONSTITUENTS OF SOPHORA MOLLIS AND THEIR POTENTIAL ROLE IN CLINICAL PHARMACY AND PHYSIOTHERAPY-BASED MANAGEMENT OF INFLAMMATORY CONDITIONS. Frontier in Medical and Health Research. 4, 6 (Jun. 2026), 3335–3350.